Company / Shareholders' Equity
ARVINAS, INC. Shareholders' Equity History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$433.9M
FY2025
5-year range
$226.6M / $660.0M
FY2021-FY2025
Trend
-22.8%
vs FY2024
Sector context
#104 of 213
Health Care
What the data says
At $434M, ARVINAS, INC.'s shareholders' equity ranks #104 of 213 in the Health Care sector. Shareholders' Equity has fluctuated over the past 9 years, ranging from -$61M in FY2019 to $660M in FY2023.
Based on SEC 10-K filings.
$434M in FY2025 with a 5-year CAGR of -7.5%.
Declined from $660M to $434M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -12.3%
- 5-Year CAGR
- -7.5%
- 10-Year CAGR
- -
Sector benchmark
#104 of 213 in Health CareTop 49% of 213This company $433.9M Sector average $2.5B
▼
-83.0% below sector average
Key checks
Key Insights
- 5-year CAGR of -7.5%, indicating a declining trend.
- In FY2025, shareholders' equity decreased 22.8% year-over-year.
- Ranks #104 out of 213 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.85 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $433.9M | -22.8% |
| FY2024 | $561.7M | -14.9% |
| FY2023 | $660.0M | +2.8% |
| FY2022 | $642.2M | +183.4% |
| FY2021 | $226.6M | -64.7% |
| FY2020 | $642.2M | +1148.8% |
| FY2019 | -$61.2M | -144.8% |
| FY2018 | $136.6M | +323.1% |
| FY2017 | -$61.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026